Vifor Pharma Ltd.
CIK 0001416422 Name as filed on the most recent filing
Filed as Vifor Pharma Ltd. (9)
67 transaction lines · from 9 filings · filed 2020-07-07 to 2021-10-13 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2021-10-12 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 4,000,000 disposed | 39.43 | 157,720,000.00 | Form 4, filing 0000899243-21-040141 | |
| 2020-08-03 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 31,823 disposed | 53.62 | 1,706,307.89 | Form 4, filing 0000899243-20-021031 | |
| 2020-08-03 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 16,650 disposed | 54.58 | 908,806.95 | Form 4, filing 0000899243-20-021031 | |
| 2020-08-03 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 785 disposed | 52.92 | 41,540.24 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-31 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 29,699 disposed | 52.57 | 1,561,252.67 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-31 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 10,009 disposed | 51.74 | 517,867.66 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-31 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 694 disposed | 54.33 | 37,704.19 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-30 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 24,458 disposed | 54.43 | 1,331,354.11 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-30 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 22,467 disposed | 54.85 | 1,232,283.50 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-30 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 1,156 disposed | 53.37 | 61,692.48 | Form 4, filing 0000899243-20-021031 | |
| 2020-07-29 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 76,321 disposed | 52.69 | 4,021,361.12 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-29 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 9,328 disposed | 51.51 | 480,523.52 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-29 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 2,363 disposed | 53.15 | 125,594.63 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-28 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 33,370 disposed | 53.38 | 1,781,220.52 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-28 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 6,790 disposed | 54.18 | 367,896.46 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-27 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 23,446 disposed | 53.17 | 1,246,523.00 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-27 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 10,790 disposed | 53.66 | 578,952.56 | Form 4, filing 0000899243-20-020673 | |
| 2020-07-24 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 15,689 disposed | 52.31 | 820,762.19 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-24 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 9,961 disposed | 52.86 | 526,544.44 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-24 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 400 disposed | 53.58 | 21,430.00 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-23 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 22,148 disposed | 53.54 | 1,185,841.57 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-23 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 6,055 disposed | 55.78 | 337,732.76 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-23 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 5,452 disposed | 54.50 | 297,154.72 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-23 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 900 disposed | 56.19 | 50,567.49 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-22 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 49,028 disposed | 55.45 | 2,718,744.78 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-22 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 23,441 disposed | 55.85 | 1,309,123.59 | Form 4, filing 0000899243-20-020448 | |
| 2020-07-21 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 81,266 disposed | 55.44 | 4,505,655.22 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-21 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 6,263 disposed | 56.20 | 351,976.84 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-20 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 37,596 disposed | 56.18 | 2,111,989.14 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-20 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 17,002 disposed | 55.70 | 947,064.11 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-17 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 25,577 disposed | 55.23 | 1,412,556.33 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-17 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 22,196 disposed | 56.58 | 1,255,876.32 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-17 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 117 disposed | 57.03 | 6,672.85 | Form 4, filing 0000899243-20-019818 | |
| 2020-07-16 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 27,340 disposed | 56.03 | 1,531,769.98 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-16 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 20,801 disposed | 56.77 | 1,180,810.37 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-16 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 18,888 disposed | 57.99 | 1,095,292.45 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-16 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 6,471 disposed | 58.55 | 378,867.99 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-15 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 63,985 disposed | 59.43 | 3,802,340.62 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-15 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 22,313 disposed | 58.65 | 1,308,630.67 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-14 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 68,732 disposed | 58.16 | 3,997,659.32 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-14 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 18,241 disposed | 58.62 | 1,069,334.85 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-14 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 13,027 disposed | 56.91 | 741,323.58 | Form 4, filing 0000899243-20-019424 | |
| 2020-07-13 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 41,292 disposed | 56.71 | 2,341,813.84 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-13 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 23,366 disposed | 58.77 | 1,373,289.92 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-13 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 14,261 disposed | 59.87 | 853,827.46 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-13 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 11,502 disposed | 57.80 | 664,808.70 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-13 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 9,579 disposed | 60.68 | 581,287.25 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-10 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 35,716 disposed | 60.02 | 2,143,556.46 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-10 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 9,223 disposed | 59.50 | 548,752.82 | Form 4, filing 0000899243-20-019014 | |
| 2020-07-10 |
ChemoCentryx, Inc. CCXI |
S, Open-market sale | 905 disposed | 60.62 | 54,862.64 | Form 4, filing 0000899243-20-019014 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Vifor Pharma Ltd., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001416422
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6